Reuters logo
BRIEF-Cellectar Biosciences gets additional patent for CLR 131, CLR 125 in Japan
October 17, 2017 / 12:58 PM / a month ago

BRIEF-Cellectar Biosciences gets additional patent for CLR 131, CLR 125 in Japan

Oct 17 (Reuters) - Cellectar Biosciences Inc

* Cellectar Biosciences receives additional Japanese patent for CLR 131 and CLR 125 for the treatment of various solid tumors

* Japanese patent office granted it a patent covering both composition of matter and method of use for CLR 131 and CLR 125​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below